Neurology · 2020 · 11 citations · 0 references
Life SciencesNeurologyPharmacotherapyClinical ImmunologyImmunopathologyNeuroimmunologyDemyelinating DiseasesDemyelinating DisordersMultiple SclerosisMultiple Sclerosis PharmacotherapyMultiple Sclerosis ImmunopathogenesisMultiple Sclerosis ImmunopathologyMultiple Sclerosis PathologyMultiple Sclerosis TherapyOcrelizumab Therapy
To report a case of progressive multifocal leukoencephalopathy (PML) occurring after two years of ocrelizumab monotherapy in a patient with progressive multiple sclerosis (MS) without prior immunomodulatory medication.